BCM
SURF

Beddow Capital Management’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Beddow Capital Management’s Portfolio SURF Stock Details SURF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-25,000
Closed -$47K – 53
2019
Q4 		$47K Buy
+25,000
New +$41.6K 0.03% 49

Other funds holding SURF

AVAI
Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Beddow Capital Management's SURF Position: Q1 2020 in Review

Beddow Capital Management sold out of Surface Oncology, Inc. Common Stock (SURF) in Q1 2020, closing a stake of 25,000 shares — an estimated $47K sold.

Beddow Capital Management first reported a position in SURF in Q4 2019 and held it in 1 quarter. The position peaked at $47K in Q4 2019. 29 funds tracked by Wall St. Rank hold SURF as of Q1 2020.

  • Beddow Capital Management reported no remaining Surface Oncology, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Beddow Capital Management sold 25,000 Surface Oncology, Inc. Common Stock shares in Q1 2020, an estimated $47K.
  • Beddow Capital Management first reported a position in Surface Oncology, Inc. Common Stock in Q4 2019 and held it in 1 quarter.
  • Beddow Capital Management's Surface Oncology, Inc. Common Stock position peaked at $47K in Q4 2019.
  • 29 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q1 2020.

Based on Beddow Capital Management's 13F filing for Q1 2020, filed 7 May 2020.